Construction and Application of Biobanks for Infectious Diseases: Focus on SARS-CoV-2-Reference-Cited by-同舟云学术

Construction and Application of Biobanks for Infectious Diseases: Focus on SARS-CoV-2

Published:2022-01-01 Issue:2022 Volume:2 Page:40-47
ISSN:2688-8130
Container-title:Innovations in Digital Health, Diagnostics, and Biomarkers
language:en
Short-container-title:

Author:

Medina Plebeian B.¹,Garcia Deborah Leiolani²,Cheong Io Hong³,Lin Raymond T. P.⁴,Kozlakidis Zisis⁵^ORCID

Affiliation:

1. Department of Health, Research Institute for Tropical Medicine, Manila, Philippines

2. Independent Consultant, San Francisco CA, USA

3. Smoke-free & Healthy Life Association of Macau, Macau, China

4. National University Hospital Singapore, National University of Singapore, Singapore

5. International Agency for Research on Cancer, World Health Organization, Lyon, France

Abstract

ABSTRACT Biobanks are foundational infrastructures that collect and provide standardized, high-quality, and research-ready biological material and associated data. The advent of high-throughput technologies has further supported the creation of biobanks globally. However, the same rate of growth has not occurred in the field of infectious diseases, where biobanks are significantly fewer as compared to other scientific fields such as oncology. This narrative review presents the main aspects that need to be taken into consideration for the construction and application of biological sample infrastructure for infectious diseases, with a number of examples taken from the recent COVID-19 pandemic.

Publisher

Innovative Healthcare Institute

Subject

General Medicine

Link

https://meridian.allenpress.com/innovationsjournals-IDDB/article-pdf/2/2022/40/3049949/i2688-8130-2-2022-40.pdf

Reference87 articles.

1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382: 1199– 1207.

2. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 145– 151.

3. Sohrabi C, Alsafi Z, O'Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020; 76: 71– 76.

4. Lu R, Niu P, Zhao L, et al. Sequencing the complete genome of COVID-19 virus from clinical samples using the Sanger method. China CDC Wkly. 2020; 2: 1– 6.

5. Qiang W, Yanhai W, Juncai M, et al. Description of the first strain of 2019-nCoV, C-tan-nCoV Wuhan strain—National Pathogen Resource Center, China, 2020. China CDC Wkly. 2020; 2: 81– 83.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Regulatory Frameworks for Biobanking in Southeast Asia;Biopreservation and Biobanking;2024-09-09

2. Data Protection in Healthcare-Integrated Biobanking;Innovations in Digital Health, Diagnostics, and Biomarkers;2023-01-01

3. Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks;Biosafety and Health;2022-08

4. Highlights from 2022: Innovations in Digital Health, Diagnostics, and Biomarkers;Innovations in Digital Health, Diagnostics, and Biomarkers;2022-01-01